Advancements in Oncology: Latest Developments in Cancer Treatment
Update: 2025-08-06
Description
Lantern Pharma's subsidiary Starlight Therapeutics has received FDA clearance to begin a Phase Ib/2a clinical trial for glioblastoma multiforme treatment. Eloro Resources Ltd. reports positive assay results from drilling program in Bolivia. Additionally, a genetic discovery holds promise for enhancing cancer immunotherapy, particularly in ovarian clear cell carcinoma patients.
Comments
In Channel



